Form 4 for AXGN Axogen, Inc.
Accepted 2025-12-17 00:00:00 ET · period of report 2025-12-16 · accession 0001400568-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-17 | 2025-12-16 | AXGN | Wendell Amy McBride | Dir | M - OptEx | $6.91 | +43.7K | 137.5K | +47% | +$302.0K |
| DM | 2025-12-17 | 2025-12-16 | AXGN | Wendell Amy McBride | Dir | S - Sale+OE | $29.31 | -43.7K | 112.1K | -28% | -$1.28M |
| DM | 2025-12-17 | 2025-12-16 | AXGN | Wendell Amy McBride | Dir | M - OptEx | $0.00 | -43.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-16 | M | A | 20,436 | $6.30 | 119,262 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-16 | M | A | 5,000 | $8.95 | 98,826 | D | — | — | |
| 3 | Common | Common Stock | 2025-12-16 | S | D | 18,248 | $29.31 | 93,826 | D | — | — | (F1) The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.99 to $29.63 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2025-12-16 | S | D | 5,000 | $29.31 | 132,510 | D | — | — | (F1) The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.99 to $29.63 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2025-12-16 | S | D | 20,436 | $29.31 | 112,074 | D | — | — | (F1) The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.99 to $29.63 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| 6 | Common | Common Stock | 2025-12-16 | M | A | 18,248 | $7.04 | 137,510 | D | — | — | |
| 7 | Derivative | Stock Option (right to purchase) | 2025-12-16 | M | D | 18,248 | $0.00 | 0 | D | $7.04 · — to 2034-06-06 | 18,248 Common Stock | (F4) Board of Directors' non-qualified stock option grant that vested in full June 6, 2025. |
| 8 | Derivative | Stock Option (right to purchase) | 2025-12-16 | M | D | 5,000 | $0.00 | 0 | D | $8.95 · — to 2026-12-29 | 5,000 Common Stock | (F2) Board of Directors' non-qualified stock option grant that vested in full May 26, 2017. |
| 9 | Derivative | Stock Option (right to purchase) | 2025-12-16 | M | D | 20,436 | $0.00 | 0 | D | $6.30 · — to 2033-09-01 | 20,436 Common Stock | (F3) Board of Directors' non-qualified stock option grant that vested in full September 1, 2024. |